X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8959) 8959
Publication (683) 683
Book Review (75) 75
Book Chapter (14) 14
Book / eBook (11) 11
Conference Proceeding (7) 7
Dissertation (7) 7
Data Set (3) 3
Magazine Article (2) 2
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7223) 7223
antimetabolites, antineoplastic - pharmacology (4905) 4905
oncology (3682) 3682
animals (3157) 3157
index medicus (3148) 3148
female (3029) 3029
male (2844) 2844
pharmacology & pharmacy (2482) 2482
antimetabolites, antineoplastic - therapeutic use (2024) 2024
deoxycytidine - analogs & derivatives (1937) 1937
antimetabolites, antineoplastic - administration & dosage (1845) 1845
mice (1826) 1826
cancer (1788) 1788
cell line, tumor (1769) 1769
chemotherapy (1750) 1750
middle aged (1667) 1667
aged (1475) 1475
fluorouracil - pharmacology (1467) 1467
5-fluorouracil (1361) 1361
adult (1275) 1275
antimetabolites, antineoplastic - adverse effects (1207) 1207
apoptosis (1159) 1159
tumor cells, cultured (1040) 1040
deoxycytidine - pharmacology (1023) 1023
apoptosis - drug effects (994) 994
gemcitabine (994) 994
antimetabolites, antineoplastic - pharmacokinetics (953) 953
dose-response relationship, drug (922) 922
expression (919) 919
fluorouracil (806) 806
rats (775) 775
drug resistance, neoplasm (761) 761
azacitidine - pharmacology (747) 747
treatment outcome (745) 745
fluorouracil - administration & dosage (742) 742
cell proliferation - drug effects (701) 701
cell survival - drug effects (695) 695
antineoplastic combined chemotherapy protocols - therapeutic use (691) 691
antineoplastic agents - pharmacology (674) 674
therapy (671) 671
methotrexate (640) 640
fluorouracil - therapeutic use (627) 627
biochemistry & molecular biology (623) 623
deoxycytidine - administration & dosage (615) 615
deoxycytidine - therapeutic use (611) 611
research (595) 595
azacitidine - analogs & derivatives (593) 593
pancreatic neoplasms - drug therapy (577) 577
carcinoma (556) 556
time factors (553) 553
neoplasms - drug therapy (545) 545
dna methylation (539) 539
mice, nude (526) 526
drug synergism (521) 521
analysis (513) 513
pharmacology/toxicology (513) 513
aged, 80 and over (505) 505
colorectal neoplasms - drug therapy (495) 495
cells (494) 494
medicine & public health (488) 488
care and treatment (487) 487
methotrexate - pharmacology (486) 486
antimetabolites, antineoplastic - chemistry (485) 485
pancreatic cancer (478) 478
toxicity (466) 466
pharmacokinetics (458) 458
tumors (454) 454
capecitabine (452) 452
blotting, western (449) 449
pancreatic neoplasms - pathology (439) 439
colorectal cancer (436) 436
cell division - drug effects (427) 427
cytarabine - pharmacology (422) 422
cell biology (421) 421
reverse transcriptase polymerase chain reaction (420) 420
in-vitro (419) 419
fluorouracil - adverse effects (417) 417
antineoplastic agents (402) 402
xenograft model antitumor assays (402) 402
antimetabolites, antineoplastic - metabolism (401) 401
cancer research (401) 401
gene expression (396) 396
inhibition (396) 396
mice, inbred balb c (396) 396
gene expression regulation, neoplastic - drug effects (392) 392
hematology (389) 389
deoxycytidine - adverse effects (388) 388
antimetabolites, antineoplastic - toxicity (379) 379
enzyme inhibitors - pharmacology (378) 378
gene expression regulation, neoplastic (375) 375
pharmacology (372) 372
drug administration schedule (371) 371
resistance (367) 367
fluorouracil - pharmacokinetics (366) 366
drug resistance (365) 365
cisplatin (364) 364
survival (363) 363
breast neoplasms - drug therapy (361) 361
leukemia (359) 359
adenocarcinoma - drug therapy (358) 358
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8581) 8581
Chinese (168) 168
Japanese (65) 65
Russian (44) 44
French (38) 38
German (38) 38
Spanish (16) 16
Italian (11) 11
Polish (6) 6
Czech (5) 5
Dutch (3) 3
Hungarian (3) 3
Swedish (3) 3
Norwegian (2) 2
Croatian (1) 1
Korean (1) 1
Kurdish (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The Journal of Immunology, ISSN 0022-1767, 07/2009, Volume 183, Issue 1, pp. 137 - 144
Journal Article
Oncogene, ISSN 0950-9232, 04/1999, Volume 18, Issue 13, pp. 2241 - 2251
Previous studies have demonstrated a synergistic interaction between rhuMAb HER2 and the cytotoxic drug cisplatin in human breast and ovarian cancer cells. To... 
Chemotherapy | Breast cancer | Synergy | Multiple drug effects analysis | HER-2/neu (c-erbB-2) | HER2/NEU-OVEREXPRESSING METASTATIC BREAST | synergy | GROWTH-FACTOR-RECEPTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTINEOPLASTIC AGENTS | breast cancer | MONOCLONAL-ANTIBODY | OVARIAN-CANCER | SALIVARY-GLAND | chemotherapy | ENDOMETRIAL CANCER | CELL BIOLOGY | C-ERBB-2 PROTEIN | ONCOLOGY | multiple drug effects analysis | TUMOR NECROSIS FACTOR | GENETICS & HEREDITY | GENE-PRODUCT | Recombinant Proteins - therapeutic use | Doxorubicin - therapeutic use | Adenocarcinoma - pathology | Receptor, ErbB-2 - genetics | Humans | Neoplasm Proteins - immunology | Antibodies, Monoclonal - therapeutic use | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Vinblastine - therapeutic use | Topoisomerase II Inhibitors | Antimetabolites, Antineoplastic - pharmacology | Receptor, ErbB-2 - antagonists & inhibitors | Receptor, ErbB-2 - immunology | Phosphorylation - drug effects | Neoplasm Proteins - genetics | Receptor, ErbB-2 - biosynthesis | Antibodies, Monoclonal - pharmacology | Etoposide - pharmacology | Combined Modality Therapy | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Drug Synergism | Antimetabolites, Antineoplastic - therapeutic use | Adenocarcinoma - therapy | Antibiotics, Antineoplastic - therapeutic use | Mice, Nude | Cyclophosphamide - pharmacology | Immunization, Passive | Fluorouracil - pharmacology | Mice | Cell Cycle - drug effects | Trastuzumab | Neoplasm Transplantation | Paclitaxel - pharmacology | Antibiotics, Antineoplastic - pharmacology | Antineoplastic Agents, Alkylating - pharmacology | Transplantation, Heterologous | Fluorouracil - antagonists & inhibitors | Cyclophosphamide - therapeutic use | Breast Neoplasms - therapy | Antibodies, Monoclonal, Humanized | Fluorouracil - therapeutic use | Protein Processing, Post-Translational - drug effects | Female | Antineoplastic Agents - pharmacology | Thiotepa - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Neoplasm Proteins - biosynthesis | Etoposide - therapeutic use | Treatment Outcome | Cisplatin - pharmacology | Recombinant Proteins - pharmacology | Paclitaxel - therapeutic use | Neoplasms, Hormone-Dependent - therapy | Animals | Breast Neoplasms - pathology | Neoplasms, Hormone-Dependent - pathology | Vinblastine - pharmacology | Neoplasms, Hormone-Dependent - drug therapy | Doxorubicin - pharmacology | Drug Screening Assays, Antitumor
Journal Article
International Journal of Oncology, ISSN 1019-6439, 6/2015, Volume 46, Issue 6, pp. 2327 - 2334
Journal Article
ACS Applied Materials and Interfaces, ISSN 1944-8244, 07/2014, Volume 6, Issue 14, pp. 11413 - 11423
Journal Article
Endocrine-Related Cancer, ISSN 1351-0088, 2016, Volume 23, Issue 8, pp. 625 - 633
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 2014, Volume 11, Issue 5, pp. 282 - 298
Journal Article